Trial Profile
A clinical study of Tocilizumab (TCZ) in Giant cell arteritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Giant cell arteritis
- Focus Therapeutic Use
- 17 Jul 2018 New trial record
- 16 Jun 2018 The clinical and analytical improvement results (n=36) presented at the 19th Annual Congress of the European League Against Rheumatism